These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17261662)

  • 1. Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study.
    Khush KK; Waters DD; Bittner V; Deedwania PC; Kastelein JJ; Lewis SJ; Wenger NK
    Circulation; 2007 Feb; 115(5):576-83. PubMed ID: 17261662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study.
    Waters DD; LaRosa JC; Barter P; Fruchart JC; Gotto AM; Carter R; Breazna A; Kastelein JJ; Grundy SM
    J Am Coll Cardiol; 2006 Nov; 48(9):1793-9. PubMed ID: 17084252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study).
    Johnson C; Waters DD; DeMicco DA; Breazna A; Bittner V; Greten H; Grundy SM; LaRosa JC
    Am J Cardiol; 2008 Nov; 102(10):1312-7. PubMed ID: 18993147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarction.
    Strandberg TE; Holme I; Faergeman O; Kastelein JJ; Lindahl C; Larsen ML; Olsson AG; Pedersen TR; Tikkanen MJ;
    Am J Cardiol; 2009 May; 103(10):1381-5. PubMed ID: 19427432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial.
    Mark DB; Knight JD; Cowper PA; Davidson-Ray L; Anstrom KJ
    Am Heart J; 2008 Oct; 156(4):698-705. PubMed ID: 18926150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
    Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
    LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
    Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
    Patti G; Pasceri V; Colonna G; Miglionico M; Fischetti D; Sardella G; Montinaro A; Di Sciascio G
    J Am Coll Cardiol; 2007 Mar; 49(12):1272-8. PubMed ID: 17394957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study.
    Wenger NK; Lewis SJ; Welty FK; Herrington DM; Bittner V;
    Heart; 2008 Apr; 94(4):434-9. PubMed ID: 18070940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).
    Ho JE; Bittner V; Demicco DA; Breazna A; Deedwania PC; Waters DD
    Am J Cardiol; 2010 Apr; 105(7):905-11. PubMed ID: 20346304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction.
    Deswal A; Bozkurt B
    Am J Cardiol; 2006 Apr; 97(8):1228-31. PubMed ID: 16616031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.
    Patti G; Chello M; Candura D; Pasceri V; D'Ambrosio A; Covino E; Di Sciascio G
    Circulation; 2006 Oct; 114(14):1455-61. PubMed ID: 17000910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of depression to death or hospitalization in patients with heart failure.
    Sherwood A; Blumenthal JA; Trivedi R; Johnson KS; O'Connor CM; Adams KF; Dupree CS; Waugh RA; Bensimhon DR; Gaulden L; Christenson RH; Koch GG; Hinderliter AL
    Arch Intern Med; 2007 Feb; 167(4):367-73. PubMed ID: 17325298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).
    Jaarsma T; van der Wal MH; Lesman-Leegte I; Luttik ML; Hogenhuis J; Veeger NJ; Sanderman R; Hoes AW; van Gilst WH; Lok DJ; Dunselman PH; Tijssen JG; Hillege HL; van Veldhuisen DJ;
    Arch Intern Med; 2008 Feb; 168(3):316-24. PubMed ID: 18268174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
    Shepherd J; Kastelein JJ; Bittner V; Deedwania P; Breazna A; Dobson S; Wilson DJ; Zuckerman A; Wenger NK;
    J Am Coll Cardiol; 2008 Apr; 51(15):1448-54. PubMed ID: 18402899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
    Sever PS; Poulter NR; Dahlof B; Wedel H;
    J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study).
    Spies C; Farzaneh-Far R; Na B; Kanaya A; Schiller NB; Whooley MA
    Am J Cardiol; 2009 Oct; 104(7):883-9. PubMed ID: 19766751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
    Zhao SP; Peng DQ; Yu BL; Huo Y;
    Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure.
    Lipinski MJ; Cauthen CA; Biondi-Zoccai GG; Abbate A; Vrtovec B; Khan BV; Vetrovec GW
    Am J Cardiol; 2009 Dec; 104(12):1708-16. PubMed ID: 19962481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.